How effective is the additional administration of COMT inhibitors compared to placebo in the treatment of PD patients with motor fluctuations, and what are the differences in terms of safety and tolerability among the approved COMT inhibitors for the treatment of PD patients with fluctuations? Here, COMT is linked to Parkinson disease.